PillCisatracurium Besylate
Cisatracurium Besylate
3 active makers
soon
soon
soon
soon
Medicaid dispensing volume
No Medicaid utilization on record for this drug concept yet. Quarterly volume (CMS State Drug Utilization Data) loads with the utilization ETL.
Who makes it3 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Meitheal Pharmaceuticals Inc. | unknown | 6 | SUPPLYING |
| Fresenius Kabi USA, LLC | unknown | 3 | SUPPLYING |
| Hospira, Inc. | unknown | 3 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- May 6, 2026RESOLVEDShortage resolved: Cisatracurium Besylate Injection (Hospira, Inc., a Pfizer Company)
Cisatracurium Besylate Injection — reported in shortage by Hospira, Inc., a Pfizer Company. Therapeutic category: Analgesia/Addiction.
- May 6, 2026SHORTAGEDrug shortage: Cisatracurium Besylate Injection (Hospira, Inc., a Pfizer Company)
Cisatracurium Besylate Injection — reported in shortage by Hospira, Inc., a Pfizer Company. Therapeutic category: Analgesia/Addiction.
- Jan 27, 2021RECALLRecall (Class I): Cisatracurium Besylate Injection, USP, 10mg per 5mL (2 mg per mL), Single-Dose Vial (NDC 71288-712-05), packaged as 10 …
Labeling: Label mix-up: Carton of Cisatracurium Besylate Injection, USP was observed to contain ten vials mislabeled as Phenylephrine Hydrochloride Injection, USP, but confirmed to contain Cisatracurium — Recalling firm: Meitheal Pharmaceuticals Inc — Nationwide USA
- Apr 5, 2016RECALLRecall (Class II): Cisatracurium Besylate Injection, 20 mg per 10 mL (2 mg per mL), For intravenous injection, 10 mL Multiple Dose Vial, R…
Incorrect/ Undeclared Excipient: Firm is recalling product due to an incorrect statement of Preservative free on the individual carton label. The vial label and outer carton label contain the correct statement of 0.9% benzyl alcohol added as a preservative. — Recalling firm: Fresenius Kabi USA, LLC — Nationwide and Puerto Rico